| Title: |
LBA46 SAKK 11/16, a phase IIa trial evaluating overall survival (OS) for recurrent/metastatic Head & neck squamous cell carcinoma (RMHNSCC) patients (pts) progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy |
| Authors: |
Mach, N.; Fernandez, E.; Vernet, R.; O. Vonrohr; Urwyler, M.; Charrier, E.; Belkouch, M-C.; Saingier, V.; F. Courtout; C. de Vito; Rubin, O.; Ancrenaz, V.; Grogg, J.N.; Renaux, J.; Gysel, K.; Müller, G.; Brezina, T.; Rordorf, T.; Joerger, M.; Michielin, O.A. |
| Source: |
Annals of Oncology ; volume 34, page S1286 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2023 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.annonc.2023.10.040 |
| Availability: |
http://dx.doi.org/10.1016/j.annonc.2023.10.040; https://api.elsevier.com/content/article/PII:S0923753423041844?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753423041844?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.9C0C74B1 |
| Database: |
BASE |